Aprepitant 68462-0583-85
- Manufacturer
- Glenmark Pharmaceuticals Inc., Usa
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 12, 2017
- Listing Expires
- December 31, 2027
- Application
- ANDA207777
Need to source Aprepitant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Aprepitant | 40 mg/1 |
Drug Class
Substance P/Neurokinin-1 Receptor Antagonist [EPC]Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A4 Inducers [MoA]
Selected Package
68462-0583-85Selected5 BLISTER PACK in 1 CARTON (68462-583-85) / 1 CAPSULE in 1 BLISTER PACK
Other packages for this product(2)
1 BLISTER PACK in 1 CARTON (68462-583-11) / 10 CAPSULE in 1 BLISTER PACK
1 BLISTER PACK in 1 CARTON (68462-583-40) / 1 CAPSULE in 1 BLISTER PACK